Series A · BiotechN-Zyme Biomedical: Series ADeveloping first-in-class therapies targeting pepsin for reflux diseasePublished Oct 4, 2026By RoundOS Funding deskFunding historyJul 22, 2026Series A · This round$4.6MSourcesbusinesswire.com↗
WyLWyL provides home nursing, personal care and medically supported housing in Japan.~¥1.5BUndisclosed · Nov 18, 2026
PulmoGatePulmoGate develops remote specialist review and medical AI tools for interstitial lung disease.~¥330MSeed · Nov 18, 2026
Isomorphic LabsBuilds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas$5BSeries C · Nov 17, 2026
NovAccelDevelops compact superconducting accelerators to produce medical radioisotopes.~¥290MPost-seed extension · Nov 17, 2026